KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bausch Health Companies (BHC) Finished Goods (2016 - 2018)

Bausch Health Companies (BHC) has disclosed Finished Goods for 7 consecutive years, with $564.0 million as the latest value for Q4 2018.

  • Quarterly Finished Goods fell 9.9% to $564.0 million in Q4 2018 from the year-ago period, while the trailing twelve-month figure was $564.0 million through Dec 2018, down 9.9% year-over-year, with the annual reading at $564.0 million for FY2018, 9.9% down from the prior year.
  • Finished Goods hit $564.0 million in Q4 2018 for Bausch Health Companies, down from $584.0 million in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $843.0 million in Q2 2015 to a low of $564.0 million in Q4 2018.
  • Historically, Finished Goods has averaged $658.1 million across 5 years, with a median of $618.0 million in 2018.
  • Biggest five-year swings in Finished Goods: soared 34.96% in 2015 and later dropped 16.56% in 2016.
  • Year by year, Finished Goods stood at $603.9 million in 2014, then skyrocketed by 34.96% to $815.0 million in 2015, then dropped by 16.56% to $680.0 million in 2016, then decreased by 7.94% to $626.0 million in 2017, then decreased by 9.9% to $564.0 million in 2018.
  • Business Quant data shows Finished Goods for BHC at $564.0 million in Q4 2018, $584.0 million in Q3 2018, and $589.0 million in Q2 2018.